|
Markt geschlossen -
NYSE
22:00:00 03.09.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 2.620 USD | +1.16% |
|
+0.38% | +45.56% |
| 12.08. | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 12.08. | Protalix BioTherapeutics, Inc. legt Ergebnisse für das zweite Quartal und das erste Halbjahr zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.16% | +0.38% | +12.93% | +33.67% | +45.56% | +63.75% | +32.32% | +62.73% | -56.33% | 209 Mio. | |
| -0.04% | -1.40% | +3.41% | +7.49% | +7.90% | +57.16% | +108.15% | +346.81% | +1’408.91% | 1’034 Mrd. | |
| +1.17% | +4.76% | +9.44% | +24.72% | +34.54% | +56.42% | +73.50% | +59.07% | +133.35% | 663 Mrd. | |
| -0.58% | +0.80% | +6.16% | +19.84% | +13.88% | +22.82% | +75.58% | +133.12% | +305.82% | 462 Mrd. | |
| +2.09% | -2.06% | +0.14% | +14.41% | +8.62% | +32.28% | +37.41% | -2.26% | +46.77% | 344 Mrd. | |
| 0.00% | +5.36% | +5.48% | +15.68% | +19.82% | +27.40% | +46.97% | +57.51% | +68.79% | 307 Mrd. | |
| +1.42% | +0.26% | +5.62% | -8.05% | -11.92% | -0.52% | +13.51% | +42.74% | +145.95% | 251 Mrd. | |
| +0.29% | +1.63% | +17.22% | +31.31% | +35.69% | +56.46% | +73.00% | +96.19% | +161.60% | 239 Mrd. | |
| -0.03% | +2.13% | -0.25% | +10.95% | -7.29% | -17.30% | -53.65% | -4.21% | +97.87% | 207 Mrd. | |
| +1.08% | +1.59% | +15.30% | +17.23% | +23.20% | +33.83% | +97.29% | +110.14% | +96.67% | 186 Mrd. | |
| -0.72% | +2.82% | +15.10% | +13.69% | +15.70% | +16.22% | -19.48% | -38.49% | -17.14% | 165 Mrd. | |
| +0.22% | +1.90% | +18.53% | +30.26% | +23.07% | +40.68% | +58.92% | +181.73% | +486.65% | 141 Mrd. | |
| +0.64% | +1.70% | +4.00% | +24.43% | +26.23% | +43.35% | +9.79% | +3.78% | +20.83% | 138 Mrd. | |
| -1.15% | -1.31% | +2.38% | +3.74% | -7.80% | -11.44% | -22.65% | -13.18% | +8.57% | 107 Mrd. | |
| +0.27% | +0.78% | -2.25% | +0.81% | +2.30% | +27.19% | +34.51% | +0.97% | -9.78% | 101 Mrd. | |
| -0.45% | -2.64% | +2.50% | -9.51% | -16.94% | +4.06% | +54.18% | +53.97% | +494.53% | 70.85 Mrd. | |
| -3.11% | -1.31% | +8.29% | +18.02% | +18.39% | +26.05% | +26.27% | +53.58% | +20.35% | 58.62 Mrd. | |
| +0.33% | +1.77% | +4.71% | +42.19% | +33.32% | +75.99% | -3.01% | +3.93% | -48.02% | 56.01 Mrd. | |
| +0.86% | -3.47% | -13.28% | -2.63% | -22.85% | -36.15% | +10.67% | -0.30% | +178.29% | 44.63 Mrd. | |
| -2.32% | -2.66% | +6.27% | +11.54% | +17.33% | +95.20% | +272.15% | +286.29% | -28.50% | 43.69 Mrd. | |
| Durchschnitt | +0.07% | +0.21% | +6.09% | +14.99% | +12.94% | +30.67% | +46.27% | +71.71% | +175.76% | 231 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.22% | +0.38% | +6.28% | +14.62% | +14.13% | +36.20% | +59.68% | +122.89% | +421.29% |
- Börse
- Aktien
- A2PWSL Aktie
- Sektor Protalix BioTherapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
